Facility #2

Osaka

0 studies enrolling now · 2 studies all time

What they study most

Hepatocellular Carcinoma (HCC), Renal Cell Carcinoma

Studies at this site

• Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma — Running, not enrolling
• A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma — Completed